These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
335 related articles for article (PubMed ID: 26048626)
41. Differential impact of high and low penetrance TNFRSF1A gene mutations on conventional and regulatory CD4+ T cell functions in TNFR1-associated periodic syndrome. Pucino V; Lucherini OM; Perna F; Obici L; Merlini G; Cattalini M; La Torre F; Maggio MC; Lepore MT; Magnotti F; Galgani M; Galeazzi M; Marone G; De Rosa V; Talarico R; Cantarini L; Matarese G J Leukoc Biol; 2016 May; 99(5):761-9. PubMed ID: 26598380 [TBL] [Abstract][Full Text] [Related]
42. The expanding spectrum of low-penetrance TNFRSF1A gene variants in adults presenting with recurrent inflammatory attacks: clinical manifestations and long-term follow-up. Cantarini L; Rigante D; Merlini G; Vitale A; Caso F; Lucherini OM; Sfriso P; Frediani B; Punzi L; Galeazzi M; Cimaz R; Obici L Semin Arthritis Rheum; 2014 Jun; 43(6):818-23. PubMed ID: 24393624 [TBL] [Abstract][Full Text] [Related]
43. Clinical Significance of Serum Soluble TNF Receptor I/II Ratio for the Differential Diagnosis of Tumor Necrosis Factor Receptor-Associated Periodic Syndrome From Other Autoinflammatory Diseases. Yasumura J; Shimizu M; Toma T; Yashiro M; Yachie A; Okada S Front Immunol; 2020; 11():576152. PubMed ID: 33162992 [No Abstract] [Full Text] [Related]
52. Autoinflammatory Diseases with Periodic Fevers. Sag E; Bilginer Y; Ozen S Curr Rheumatol Rep; 2017 Jul; 19(7):41. PubMed ID: 28631068 [TBL] [Abstract][Full Text] [Related]
53. Symptoms related to tumor necrosis factor receptor 1-associated periodic syndrome, multiple sclerosis, and severe rheumatoid arthritis in patients carrying the TNF receptor superfamily 1A D12E/p.Asp41Glu mutation. Havla J; Lohse P; Gerdes LA; Hohlfeld R; Kümpfel T J Rheumatol; 2013 Mar; 40(3):261-4. PubMed ID: 23322460 [TBL] [Abstract][Full Text] [Related]
54. Tumour necrosis factor receptor-associated periodic syndrome caused by a rare mutation in the TNFRSF1A gene, and with excellent response to etanercept treatment. Cantarini L; Lucherini OM; Galeazzi M; Fanti F; Simonini G; Baldari CT; Laghi Pasini F; De Martino M; Cimaz R Clin Exp Rheumatol; 2009; 27(5):890-1. PubMed ID: 19917181 [No Abstract] [Full Text] [Related]
55. Canakinumab treatment for patients with active recurrent or chronic TNF receptor-associated periodic syndrome (TRAPS): an open-label, phase II study. Gattorno M; Obici L; Cattalini M; Tormey V; Abrams K; Davis N; Speziale A; Bhansali SG; Martini A; Lachmann HJ Ann Rheum Dis; 2017 Jan; 76(1):173-178. PubMed ID: 27269295 [TBL] [Abstract][Full Text] [Related]
56. TNFRSF1A Gene Causing Tumor Necrosis Factor Receptor-associated Periodic Syndrome in 2 Siblings Displaying Variable Disease Severity and Discordant Heterozygosity for an MEFV E148Q Variant. Abdwani R; Abdalla E; Al Abrawi S; Al-Thihli K J Rheumatol; 2015 Aug; 42(8):1534-5. PubMed ID: 26233954 [No Abstract] [Full Text] [Related]
57. Safety and efficacy of canakinumab in Japanese patients with phenotypes of cryopyrin-associated periodic syndrome as established in the first open-label, phase-3 pivotal study (24-week results). Imagawa T; Nishikomori R; Takada H; Takeshita S; Patel N; Kim D; Lheritier K; Heike T; Hara T; Yokota S Clin Exp Rheumatol; 2013; 31(2):302-9. PubMed ID: 23380020 [TBL] [Abstract][Full Text] [Related]
58. "Trap" the diagnosis: a man with recurrent episodes of febrile peritonitis, not just familial Mediterranean fever. Arad U; Niv E; Caspi D; Elkayam O Isr Med Assoc J; 2012 Apr; 14(4):229-31. PubMed ID: 22675839 [TBL] [Abstract][Full Text] [Related]
59. First Case of TNF-Receptor-Associated Autoinflammatory Syndrome (TRAPS) in Bulgaria. Solakov PT Folia Med (Plovdiv); 2016 Sep; 58(3):211-214. PubMed ID: 27760004 [TBL] [Abstract][Full Text] [Related]
60. Real-Life Indications of Interleukin-1 Blocking Agents in Hereditary Recurrent Fevers: Data From the JIRcohort and a Literature Review. Vinit C; Georgin-Lavialle S; Theodoropoulou A; Barbier C; Belot A; Mejbri M; Pillet P; Pachlopnik J; Poignant S; Rebelle C; Woerner A; Koné-Paut I; Hentgen V Front Immunol; 2021; 12():744780. PubMed ID: 34858402 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]